Who Owns SBFM?

Sunshine Biopharma, Inc. — Institutional Ownership & 13F Holdings

$0.97

-0.01 (-1.23%)

Market Cap

$5.4M

Shares Outstanding

4,905,945

Institutional Holders

11

Total Inst. Value

$151K

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Altium Capital Management LLC$96K50,466
2UBS Group AG$38K19,885
3SBI Securities Co., Ltd.$10K5,223
4MORGAN STANLEY$7K3,834
5Farther Finance Advisors, LLC$21
6OSAIC HOLDINGS, INC.$22
7Rise Advisors, LLC$21
8Federation des caisses Desjardins du Quebec$01
9BANK OF AMERICA CORP /DE/$05
10TD Waterhouse Canada Inc.$01

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
MORGAN STANLEY-4K$7K

Related Stocks

Frequently Asked Questions

How many institutional investors hold SBFM?

As of Q1 2025, 11 institutional investors report holding SBFM (Sunshine Biopharma, Inc.) in their 13F filings.

Which hedge fund owns the most SBFM?

The largest institutional holder of SBFM is Altium Capital Management LLC with $96K in shares.

Are institutions buying or selling SBFM?

This quarter, 2 institutions opened new positions in SBFM and 3 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.